Veeva Sys Inc Stock Price, News & Analysis

Axsome Therapeutics has partnered with Veeva Systems to enhance its Digital-Centric Commercialization (DCC™) platform, aimed at optimizing marketing for CNS drugs AXS-05 and AXS-07, expected to launch next year. Veeva will provide technology, data, and consulting support, leveraging its Commercial Cloud products to improve physician-patient engagement.

The partnership underscores a significant shift in commercial strategy, focusing on innovative digital tools to streamline drug promotion and improve patient care.

Veeva Systems (NYSE: VEEV) announced the participation of Dr. Francesca Domenech Wuttke and Alessandro de Luca as keynote speakers at the 2020 Veeva Commercial & Medical Summit Online, Europe. The event, featuring over 80 sessions, focuses on digital transformation in life sciences to expedite drug market entry. Notable discussions include insights from Alexion, Boehringer Ingelheim, Lundbeck Italy, and Shionogi on advancing digital strategies. Scheduled for November 17-18, 2020, the summit aims to unite over 3,000 professionals from more than 250 companies in the sector.

Veeva Systems (NYSE: VEEV) announced that Bavarian Nordic is utilizing its Veeva CRM and Veeva Vault PromoMats for a digital product launch across the U.S. and Europe, enhancing their digital engagement capabilities. Bavarian Nordic, focused on vaccines for infectious diseases, chose Veeva to meet aggressive launch timelines and support global growth. This partnership allows for effective HCP interactions through digital channels, ensuring compliance and timely content delivery, further solidifying Veeva's role in driving digital transformation within the life sciences sector.

Veeva Systems has launched MyVeeva for Doctors, a mobile app designed to streamline healthcare professionals' access to key resources from life sciences companies. This solution aims to facilitate connections between healthcare providers and pharmaceutical firms, offering essential services like product samples and copay cards in one place. Early adopters include major companies such as GSK, Pfizer, and Sanofi, with the app currently available in select markets including the US and UK. The initiative is intended to enhance patient care by improving the efficiency of healthcare professionals.

Veeva Systems (NYSE: VEEV) has launched MyVeeva for Doctors, a mobile app aimed at enhancing healthcare professionals' access to resources from pharmaceutical and biotech companies. This initiative aims to streamline interactions between healthcare providers (HCPs) and life sciences, allowing HCPs to easily connect with key contacts and access information. Initial partnerships include major companies like Boehringer Ingelheim, GSK, and Pfizer. The app is currently available in select markets including the U.S. and U.K., with plans for expansion in 2021.

Veeva Systems (NYSE: VEEV) has announced keynote speakers for the upcoming 2020 Veeva Medical Device & Diagnostics Summit Online, featuring industry leaders from Boston Scientific, Illumina, Johnson & Johnson, and QIAGEN. The event aims to address the modernization of processes and compliance in the medical device sector, with over 1,000 professionals expected to attend. Key sessions will include insights on clinical data unification from Alcon and RIM transformation by Baxter Healthcare. The summit will take place on Oct. 28-29, 2020.

Veeva Systems (NYSE: VEEV) announced that CANbridge Pharmaceuticals has adopted Veeva Vault QualityDocs to enhance its global clinical trials. This cloud-based solution streamlines document management, ensuring compliance and audit readiness. CANbridge's previous paper-based system was resource-intensive, and the switch to Vault QualityDocs is expected to save time and improve quality assurance in their clinical studies. The initiative aims to facilitate knowledge sharing and accelerate the delivery of life-saving therapies worldwide.

Veeva Systems (NYSE: VEEV) announced that Exact Sciences has chosen the Veeva Vault Clinical Suite to enhance its clinical study processes. This suite includes Vault CDMS, Vault CTMS, and Vault eTMF which will enable Exact Sciences to manage clinical data, trials, and compliance more efficiently. The partnership aims to accelerate the development of innovative cancer diagnostics, ensuring readiness for EU IVDR and MDR regulations. Exact Sciences expects to streamline its clinical studies and improve operational efficiency through this collaboration.

Veeva Systems (NYSE: VEEV) reports growing adoption of its Vault Quality Suite, with over 300 organizations, including 13 of the top 20 global pharmaceutical companies, utilizing its applications for quality management. Key features include streamlined processes, improved collaboration, and enhanced visibility for life sciences firms. The suite supports various functionalities such as Vault Training and Vault Product Surveillance. Veeva's ongoing innovations aim to modernize quality management across industries, emphasizing the demand for unified solutions in the ever-evolving healthcare sector.